domingo, 2 de octubre de 2022

Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease - The Lancet Rheumatology

Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario